Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.4 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.4 |